Follow this preprint
Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products
Mehdi Jorfi, Nell Meosky Luo, Aditi Hazra, Fanny Herisson, Glenn Miller, James A. Toombs, David R. Walt, Paolo Bonato, Rushdy Ahmad, COVID-19 Direct-to-Consumer Task Force Investigators
doi: https://doi.org/10.1101/2020.06.25.20140236
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Mehdi Jorfi
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
2Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
Nell Meosky Luo
3Folia Health, Inc., Boston, MA, United States
Aditi Hazra
4Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
Fanny Herisson
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
Glenn Miller
5Mass General Brigham Incorporated, Boston, MA, United States
James A. Toombs
6Brigham Research Institute, Brigham and Women’s Hospital, Boston, MA, United States
David R. Walt
7Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
8Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, United States
Paolo Bonato
8Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, United States
9Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, United States
Rushdy Ahmad
8Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, United States
10See Addendum for COVID-19 Direct-to-Consumer Task Force Investigators and Affiliations
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The datasets generated during and/or analyzed during the current study are available at the Mass General Brigham Center for COVID Innovation (MGB-CCI) website.
https://covidinnovation.partners.org/diagnostics-direct-to-consumer/
Posted June 29, 2020.
Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products
Mehdi Jorfi, Nell Meosky Luo, Aditi Hazra, Fanny Herisson, Glenn Miller, James A. Toombs, David R. Walt, Paolo Bonato, Rushdy Ahmad, COVID-19 Direct-to-Consumer Task Force Investigators
medRxiv 2020.06.25.20140236; doi: https://doi.org/10.1101/2020.06.25.20140236
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (407)
- Allergy and Immunology (718)
- Anesthesia (213)
- Cardiovascular Medicine (3030)
- Dermatology (256)
- Emergency Medicine (453)
- Epidemiology (12949)
- Forensic Medicine (12)
- Gastroenterology (845)
- Genetic and Genomic Medicine (4755)
- Geriatric Medicine (439)
- Health Economics (745)
- Health Informatics (3019)
- Health Policy (1091)
- Hematology (405)
- HIV/AIDS (950)
- Medical Education (448)
- Medical Ethics (118)
- Nephrology (488)
- Neurology (4531)
- Nursing (241)
- Nutrition (669)
- Oncology (2353)
- Ophthalmology (665)
- Orthopedics (262)
- Otolaryngology (332)
- Pain Medicine (294)
- Palliative Medicine (85)
- Pathology (511)
- Pediatrics (1226)
- Primary Care Research (513)
- Public and Global Health (7118)
- Radiology and Imaging (1579)
- Respiratory Medicine (939)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (502)
- Toxicology (63)
- Transplantation (217)
- Urology (187)